Exclusive: Federal prosecutors are exploring whether prediction market bets trip insider trading laws

Federal prosecutors in SDNY are probing lucrative prediction-market bets for potential insider trading and other violations, including markets tied to the timing of Nicolás Maduro’s capture, and have met with Polymarket. The escalation raises sector regulatory and legal risk: Polymarket earlier paid $1.4M to settle with the CFTC (2022) and later registered with the CFTC (July 2025), Kalshi faces Arizona criminal charges and dozens of civil suits and state AG actions, and lawmakers and platforms are imposing new bans and surveillance rules. Expect higher compliance costs, potential trading restrictions (including bans on officials/athletes), and increased uncertainty for investments in prediction-market operators.

Analysis

Regulatory blow-ups tend to reallocate economic rents to incumbent, fully-compliant exchange operators and to vendors that sell surveillance/compliance tooling. Expect a multi-quarter surge in RFP activity from platforms seeking accredited venue status or third‑party surveillance as a way to de‑risk access to U.S. liquidity and institutional customers; that translates to recurring fee revenue for listed exchanges and multi-year contracts for market‑surveillance vendors.

The biggest operational risk is a liquidity flight from offshore, lightly‑monitored venues into either regulated markets or opaque OTC channels. If enforcement leads to meaningful withdrawal of offshore counterparties, price discovery in thin-event markets will widen spreads and reduce turnover for smaller venues for 3–12 months, creating arbitrage windows for systematic traders able to provide liquidity at scale.

A likely near‑term bifurcation: (1) regulated, capitalized exchanges that can certify surveillance will see higher take‑rates and product expansion; (2) hobbyist and offshore venues will face both funding drought and legal friction. The contrarian angle is that formalized rules from a major regulator would actually compress risk premia and increase aggregate handle over 12–36 months, benefiting those same incumbents rather than killing the product category.

Key Decisions for Investors

• Long CME (CME) 12–18 month call spread (buy 1 CME Jan-2027 220 call / sell 1 CME Jan-2027 260 call). Rationale: fee capture as event markets migrate onshore; target 1.8x reward vs max loss, allocate 1–2% of strategy AUM. Key catalyst: certification wins or new product announcements over next 6–12 months.
• Long Nasdaq (NDAQ) 9–12 month calls (buy NDAQ Sep-2026 $120 calls) size 0.5–1% AUM. Rationale: surveillance & listing services demand should increase; asymmetric payoff if RFP wins and recurring SaaS contracts materialize. Risk: tech spending delays or macro slowing could push wins out 6+ months.
• Long market‑surveillance/identity vendors via Splunk (SPLK) or NICE alternatives (buy SPLK 9–12 month calls) — modest position (0.5% AUM). Rationale: AML/KYC and pattern‑detection spend rises; win probability high within 3–9 months. Downside: competitive pricing pressure; cap losses at premium paid.
• Pairs trade for regulatory differentiation: short pure‑play small-cap gaming/crypto platforms (select names with >20% revenue from unregulated event products) and long established exchanges (CME/ICE). Size net-neutral; directional bias favors regulated exchanges if enforcement headlines persist over 3–9 months.
• Hedge trigger: if a major regulator issues clear permissive rules (safe harbor) within 12 months, take profits on calls and rotate into volatility sellers. If prosecutions or state bans mount, add to surveillance/vendor longs and widen short allocation to unregulated platform proxies.